AN APPLICATION OF BAYESIAN POPULATION PHARMACOKINETIC/PHARMACODYNAMIC MODELS TO DOSE RECOMMENDATION-Reference-Cited by-同舟云学术

AN APPLICATION OF BAYESIAN POPULATION PHARMACOKINETIC/PHARMACODYNAMIC MODELS TO DOSE RECOMMENDATION

Published:1995-05-15 Issue:9 Volume:14 Page:971-986
ISSN:0277-6715
Container-title:Statistics in Medicine
language:en
Short-container-title:Statist. Med.

Author:

Wakefield Jon,Racine-Poon Amy

Publisher

Wiley

Subject

Statistics and Probability,Epidemiology

Reference21 articles.

1. , , and ‘The population approach: rationale, methods and applications in clinical pharmacology and drug development’, in Handbook of Experimental Pharmacology, vol 110, Pharmacokinetics of Drugs, Springer-Verlag, Heidelberg, 1994.

2. A population analysis of the pharmacokinetics and pharmacodynamics of midazolam in the rat

3. Methodologic aspects of a population pharmacodynamic model for cognitive effects in Alzheimer patients treated with tacrine.

4. Results and validation of a population pharmacodynamic model for cognitive effects in Alzheimer patients treated with tacrine.

5. The place of simultaneous pharmacokinetic pharmacodynamic modeling in new drug development: trends and perspectives

Cited by 54 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Modeling antigen-specific T cell dynamics following Hepatitis B Vaccination indicates differences between conventional and regulatory T cell dynamics;Vaccine;2024-08

2. Modeling Antigen-Specific T Cell Dynamics Following Hepatitis B Vaccination indicates differences between conventional and regulatory T cell dynamics;2023-05-28

3. Estimation for dynamical systems using a population-based Kalman filter – Applications in computational biology;MathematicS In Action;2022-09-27

4. Mining Small Routine Clinical Data: A Population Pharmacokinetic Model and Optimal Sampling Times of Capecitabine and its Metabolites;Journal of Pharmacy & Pharmaceutical Sciences;2019-04-09

5. Population pharmacokinetic model of irinotecan and its metabolites in patients with metastatic colorectal cancer;European Journal of Clinical Pharmacology;2019-01-04